$200 Savings Ends in:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Day 2 - US/Eastern
- Rosanna Veggeberg - Director, Investigator Sponsored Research Unit, Fox Chase Cancer Center
Join us for an in-depth exploration of a medical education program's journey from inception to implementation and evaluation. This case study session will provide a detailed look at the entire lifecycle of a successful medical education initiative.
- Kathy Bellisle - Program Director, NEJM Group Education & Applied Knowledge, NEJM
- Alyssa Truong, MPH - Senior Director, Medical Affairs, Rigel Pharmaceuticals
This session delves into the challenges of building international programs, including cultural considerations, language barriers, and logistical hurdles. Participants will gain insights into navigating accreditation processes across different countries while maintaining program integrity. The session concludes by highlighting successful global education initiatives and discussing future trends in cross-border learning.
- Kelly Kraines - Director, Education, International Association for the Study of Lung Cancer
- Debra Mayo - Executive Director Global Medical Communications and Operations, OTSUKA
Understanding how the innovative program for Type 1 Diabetes management was developed and implemented, and how it led to significant improvements in patient outcomes and healthcare provider knowledge. Participants will gain insights into how strategic use of grants can drive impactful educational programs and the increase in healthcare providers' understanding and skills in managing Type 1 Diabetes.
Evaluating whether your approach is a short-term sprint or a sustainable long-term strategy
Embracing specialization: Moving from jack-of-all-trades to master of one
Strategies for maintaining a patient-first mentality in program development and grant applications
- Karyn Ruiz-Cordell, MA, PhD - Director, Medical Education and Data Analytics, Regeneron Pharmaceuticals
- Francine Pope - CME Manager, Department of Medicine, Icahn School of Medicine at Mount Sinai
This session will delve into the dynamic world of global investigator-initiated sponsored research (IISR). Participants will gain insights into the unique opportunities and challenges associated with conducting IISR on an international scale.
Key topics will include:
Understanding the landscape of IISR and its significance in advancing medical knowledge.
Navigating regulatory and ethical considerations across different countries.
Strategies for securing funding and support from sponsors.
Best practices for designing and managing multi-center studies.
Case studies highlighting successful global IISR projects and their impact on clinical practice.
- Peyton Wade - PharmD, Senior Specialist, Study Mgmt. & Execution, AbbVie
Explore the critical role of DEI in research, addressing current challenges, barriers to diversity, and strategies for improvement. We'll examine inclusive study design, equitable funding opportunities, and the importance of diverse collaboration and mentorship. The session will also cover methods for measuring and reporting DEI progress, featuring case studies of successful initiatives. Join us in this crucial conversation as we work together to build a more diverse, equitable, and inclusive landscape for investigator-initiated sponsored research.
- Nancy Wintering, LCSW, CCRP - Assistant Director of Research, Thomas Jefferson University, Marcus Institute
In today's rapidly evolving educational landscape, innovative instructional design is key to creating engaging, effective, and transformative learning experiences. This dynamic session explores cutting-edge approaches that are reshaping the way we conceptualize, develop, and deliver instruction across various learning environments.
- Bradley Bednarz - Co-Founder, Calibre Institute for Quality Medical Education
This session explores the healthcare disparities affecting underserved communities, particularly African-American, Hispanic, and other marginalized populations. It highlights the root causes of these disparities, such as socioeconomic, cultural, and systemic factors, and emphasizes the role of trusted community groups—like barbers, churches, and organizations addressing food insecurity and reintegration challenges for formerly incarcerated individuals—in bridging the healthcare gap. The discussion focuses on the importance of teaching cultural humility to clinicians to ensure that patients from these communities receive respectful and appropriate care. Participants will gain insights into how we can implement strategies to mitigate these barriers by enlisting the support and participation of allies and trusted members, as well as actionable approaches for developing community-centric healthcare initiatives focused on improving access, testing, communication, and trust between healthcare providers and underserved populations.
- Dean Beals - President and CEO, DKBmed
- Tyrik Jackson - Owner, Premier Barber Institute and DKBmed Advisor
In the complex world of investigator-initiated sponsored research (IISR), compliance is a critical factor that shapes collaboration between pharmaceutical companies and healthcare institutions. This session delves into the intricacies of compliance in IISR, offering insights from both industry and healthcare perspectives. Participants will gain a deeper understanding of compliance challenges and develop strategies for effective collaboration within regulatory boundaries.
- Erika Jerome, MS, MA, ACRP-CP - Manager, Investigator-Sponsored Research Unit, Fox Chase Cancer Center
Join us for an insightful panel discussion exploring the intricate relationship between pharmaceutical companies and research institutions in the realm of investigator-initiated sponsored research (IISR). This session will bring together experts from both sectors to discuss the collaborative dynamics that drive innovation and advance medical science.
Key topics will include:
The roles and responsibilities of pharma and research institutions in IISR.
Strategies for fostering transparent and ethical partnerships.
Navigating funding mechanisms and resource allocation.
Addressing potential conflicts of interest and maintaining research integrity.
Case studies showcasing successful collaborations and their impact on healthcare.
- Rosanna Veggeberg - Director, Investigator Sponsored Research Unit, Fox Chase Cancer Center
In the ever-evolving field of healthcare, medical education plays a crucial role in shaping competent and knowledgeable professionals. This session explores the dynamic interplay between accredited and non-accredited medical education, offering a comprehensive look at their respective roles, benefits, and challenges in the modern healthcare ecosystem.
- Tania Alexander - Director, Centre of Excellence, Medical Education, AstraZeneca
- Vanessa Gray - Director, Continuing Medical Education, Des Moines University Medicine and Health Sciences
Participants will explore how to effectively integrate data-driven insights with compelling narratives to enhance learning experiences and improve educational outcomes. Key topics will include:
- The fundamentals of data visualization and interpretation in a medical context.
- Techniques for crafting impactful stories that resonate with diverse audiences.
- Case studies demonstrating successful applications of data storytelling in medical education.
- Best practices for balancing factual accuracy with engaging content.
Explore the critical role of Medical Science Liaisons (MSLs) in the landscape of sponsored research during this engaging panel discussion. Our panelists, including experienced MSLs, researchers, and industry leaders, will delve into the multifaceted responsibilities and contributions of MSLs in fostering successful research collaborations.
Key topics will include:
- The strategic importance of MSLs in bridging the gap between sponsors and research institutions.
- Best practices for MSLs in supporting investigator-initiated studies and ensuring compliance with regulatory standards.
- Techniques for effective communication and relationship-building with key stakeholders.
- Case studies highlighting the impact of MSLs on research outcomes and scientific advancements.
- Randy Levitt, PhD - Director, Pharmacovigilance & Medical Affairs, Paladin Labs
- Christopher Bowie - PharmD, Medical Science Liaison-Psychiatry, US Field Medical Affairs, AbbVie
Dive into the comparative dynamics of collaborative research and investigator-initiated sponsored research (IISR) in this informative session. Participants will explore the distinct characteristics, benefits, and challenges of each research model, gaining a deeper understanding of how to leverage these approaches to advance scientific discovery.
Key topics will include:
Defining collaborative research and IISR: scope, objectives, and methodologies.
Evaluating the advantages and limitations of each model in different research contexts.
Strategies for selecting the appropriate research model based on project goals and resources.
Case studies illustrating successful implementations of collaborative research and IISR.
Best practices for managing partnerships, securing funding, and ensuring compliance.
- Matthew Kuriakose - Senior Manager of Scientific Affairs, Mallinckrodt Pharmaceuticals